EmitBio Inc.

5 clinical trials · Sponsor

Record	Firm	Date
Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting (NCT06113679)	EmitBio Inc.	2023-10-30
Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19 (NCT05817045)	EmitBio Inc.	2023-04-21
Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19 (NCT04966013)	EmitBio Inc.	2021-06-17
Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19 (NCT04662671)	EmitBio Inc.	2020-11-18
Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens (NCT04557826)	EmitBio Inc.	2020-08-31

Every clearance here is in the API, with alerts when new ones post.